Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study

BACKGROUND: The optimal duration of clopidogrel treatment after percutaneous coronary intervention (PCI) is unclear. We studied the risk of death or recurrent myocardial infarction (MI) in relation to 6- and 12-months clopidogrel treatment among MI patients treated with PCI. METHODS: Using nationwid...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sørensen, Rikke, Abildstrom, Steen Z, Weeke, Peter, Fosbøl, Emil L, Folke, Fredrik, Hansen, Morten L, Hansen, Peter R, Madsen, Jan K, Abildgaard, Ulrik, Køber, Lars, Poulsen, Henrik E, Torp-Pedersen, Christian, Gislason, Gunnar H
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2010
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2837608/
https://ncbi.nlm.nih.gov/pubmed/20113477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2261-10-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi